CEE/CIS - Poland

Domanski Zakrzewski Palinka

More informationMore information

Domanski Zakrzewski Palinka‘s practice is known for handling a broad array of matters for clients, including M&A, research and development projects, and compliance issues. The group leverages its deep regulatory bench strength to advise clients on the manufacturing and promotion of pharmaceutical products. In December 2023, Mateusz Mądry arrived to head up the department; he brings in-house experience working at the Ministry of Health, the Office for the Registration of Medicinal Products, Medical Devices and Biocidal Products, and the European Medicines Agency to the group.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Very knowledgeable, exceptional, commercial knowledge of the pharma sector, very practical approach.'

  • 'Easy to understand communication.'

  • ‘Awareness of business realities and out of the box mindset - they work together, and don't just provide legal advice.’

  • ‘Strong leadership, long-lasting relationships with organisations. Their key strength is their commercial/distribution expertise.’

  • ‘Wide experience and knowledge of multiple topics and practical aspects of the law, which makes it easier to find solutions and rapidly execute projects/solve problems.’

Key clients

  • MSD Polska sp. z o.o.
  • AstraZeneca Pharma Poland Sp. z o. o.
  • Pfizer Polska sp. z o.o.
  • Teva Pharmaceuticals Polska
  • Takeda Sp. z o.o.
  • Telemedicine Working Group
  • Mylan Healthcare sp. z o.o. (Viatris group)
  • Polish Federation of Hospitals
  • Astellas sp. z o.o.
  • GSK (GSK Commercial sp. z o.o. and GSK Services)
  • Servier Polska Sp. z o.o.
  • Bausch Health Poland Sp. z o.o.
  • AbbVie Polska Sp. z o.o.
  • Sanofi
  • Vetoquinol Biowet sp. z o.o.
  • Roche Diabetes Care Polska Sp. z o.o.
  • Super-Pharm Holding
  • Organon Polska sp. z o.o.
  • Olimp Laboratories Sp. z o.o.
  • DrEryk S.A.

Work highlights

  • Advising Takeda on the reimbursement of blockbuster drugs.
  • Advising a large Polish pharmaceutical company on compliance issues, internal procedures, risk management, and the distribution of medicinal products, as well as handling contentious matters.

Practice head

The lawyer(s) leading their teams.

Mateusz Mądry

Other key lawyers

Marcin Matczak